Literature DB >> 7361675

Strength-interval relation in the human ventricle: effect of procainamide.

J S Camardo, A M Greenspan, L N Horowitz, S R Spielman, M E Josephson.   

Abstract

The effects of procainamide on strength-interval relations were evaluated in 18 patients. At plasma concentrations of 4.3 to 13.6 micrograms/ml procainamide had minimal effects on threshold current in late diastole, but in early diastole it shifted the strength-interval curve to the right. The basic strength-interval relation (that is, decreasing refractory period as current is increased) was not altered. The control refractory period decreased by a mean of 44 ms as the current was increased from threshold to 10 mA, whereas a mean decrease of 42 ms was observed after procainamide. However, the steep portion of the strength-interval curve(absolute refractory period) was shifted to longer coupling intervals by a mean value of 24 ms. These findings suggest that procainamide may primarily affect active membrane properties, but exert little net effect on passive membrane properties late in diastole.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7361675     DOI: 10.1016/0002-9149(80)90132-0

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  3 in total

Review 1.  Can the technicalities of electrophysiological testing for ventricular tachycardia be simplified?

Authors:  D E Ward
Journal:  Br Heart J       Date:  1987-11

2.  Induction of ventricular arrhythmias by programmed ventricular stimulation: a prospective study on the effects of stimulation current on arrhythmia induction.

Authors:  P L Weissberg; A Broughton; R W Harper; A Young; A Pitt
Journal:  Br Heart J       Date:  1987-11

3.  Effect of mexiletine, amiodarone and disopyramide on the excitability and refractoriness of canine cardiac fibers: possible relation to antiarrhythmic drug action and classification.

Authors:  Y Nakaya; V Elharrar; B Surawicz
Journal:  Cardiovasc Drugs Ther       Date:  1987-08       Impact factor: 3.727

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.